|
PDHB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77080572427712E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8972046156307E-11 |
| Normal-vs-Stage2 |
1.56449964094918E-10 |
| Normal-vs-Stage3 |
3.89520005139588E-09 |
| Normal-vs-Stage4 |
1.05700004304765E-09 |
| Stage1-vs-Stage2 |
6.823800E-02 |
| Stage1-vs-Stage3 |
6.457500E-02 |
| Stage1-vs-Stage4 |
6.276400E-02 |
| Stage2-vs-Stage3 |
7.918400E-01 |
| Stage2-vs-Stage4 |
2.898800E-01 |
| Stage3-vs-Stage4 |
5.103200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69531055860261E-13 |
| Normal-vs-AfricanAmerican |
9.83479964133949E-11 |
| Normal-vs-Asian |
4.38790000000244E-05 |
| Caucasian-vs-AfricanAmerican |
9.140800E-01 |
| Caucasian-vs-Asian |
7.002600E-01 |
| AfricanAmerican-vs-Asian |
7.270800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36477504245158E-14 |
| Normal-vs-Female |
1.17049999692753E-08 |
| Male-vs-Female |
8.068300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.57209850377194E-11 |
| Normal-vs-Extreme_Weight |
1.86883841735153E-12 |
| Normal-vs-Obese |
2.27450280831931E-11 |
| Normal-vs-Extreme_Obese |
2.117200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.246800E-01 |
| Normal_Weight-vs-Obese |
8.696200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.917000E-01 |
| Extreme_Weight-vs-Obese |
8.506000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.408200E-01 |
| Obese-vs-Extreme_Obese |
3.155600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.156100E-04 |
| Normal-vs-Age(41-60Yrs) |
6.57252030578093E-13 |
| Normal-vs-Age(61-80Yrs) |
3.0142555118573E-13 |
| Normal-vs-Age(81-100Yrs) |
1.31100000000384E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.705200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.901800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.987000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.585600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.801000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.30611143701299E-12 |
| Normal-VS-Type2 PRCC |
2.79620770982092E-12 |
| Normal-VS-KIRP CIMP |
2.44329999565807E-08 |
| Normal-VS-Unclassified PRCC |
1.01750052827754E-10 |
| Type1 PRCC-VS-Type2 PRCC |
4.306100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.383900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.033400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.602000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.102200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.818400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.4714011099577E-11 |
| Normal-vs-N1 |
1.63447033685316E-12 |
| Normal-vs-N2 |
1.25350000379498E-08 |
| N0-vs-N1 |
3.944800E-01 |
| N0-vs-N2 |
1.114970E-01 |
| N1-vs-N2 |
9.536200E-02 |
|
|
